Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1956;14:757-765

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by THOMSON, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THOMSON, G. W.

(Circulation. 1956;14:757.)
© 1956 American Heart Association, Inc.


Quinidine as a Cause of Sudden Death

GEORGE W. THOMSON M.D.1

1 From the Cardiovascular Service, Lenox Hill Hospital, N. Y.

Sudden death and arterial embolism are unpredictable hazards of quinidine therapy for atrial fibrillation that act as deterrents to its most effective use. In this paper an attempt is made to determine the incidence of these accidents as reported in the literature. The mechanism of sudden death is also examined. The difficulty of determining the role of quinidine in producing these accidents in seriously ill patients is clarified.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. M. Gallagher, B. J. Hennessy, N. Edvardsson, C. M. Hart, M. S. Shannon, O. A. Obel, N. M. Al-Saady, and A. J. Camm
Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion
J. Am. Coll. Cardiol., September 4, 2002; 40(5): 926 - 933.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. P. Sharma, P. Ott, V. Hartz, J. W. Mason, and F. I. Marcus
Risk Factors for Tachycardia Events Caused by Antiarrhythmic Drugs: Experience From the ESVEM Trial
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 269 - 274.
[Abstract] [PDF]